Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

The uPA(+/+)-SCID Mouse with Humanized Liver as a Model for in Vivo Metabolism of 4-Androstene-3,17-dione

Leen Lootens, Peter Van Eenoo, Philip Meuleman, Geert Leroux-Roels and Frans T. Delbeke
Drug Metabolism and Disposition December 2009, 37 (12) 2367-2374; DOI: https://doi.org/10.1124/dmd.109.028183
Leen Lootens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Van Eenoo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip Meuleman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geert Leroux-Roels
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frans T. Delbeke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 37 no. 12 2367-2374
DOI 
https://doi.org/10.1124/dmd.109.028183
PubMed 
19741039

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received April 23, 2009
  • Accepted September 2, 2009
  • Published online November 19, 2009.

Article Versions

  • Earlier version (September 9, 2009 - 07:24).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2009 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Leen Lootens,
  2. Peter Van Eenoo,
  3. Philip Meuleman,
  4. Geert Leroux-Roels and
  5. Frans T. Delbeke
  1. Doping Control Laboratory, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Zwijnaarde, Belgium (L.L., P.V.E., F.T.D.); and Center for Vaccinology, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University and Hospital, Ghent, Belgium (P.M., G.L.-R.)
  1. Address correspondence to:
    Dr. Leen Lootens,
    DoCoLab, Ghent University, Technologiepark 30 B, 9052 Zwijnaarde, Belgium.
    E-mail: leen.lootens{at}ugent.be
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: September 2009 to January 2021

AbstractFullPdf
Sep 200935099
Oct 200917032
Nov 200931127
Dec 200964432
Jan 2010112817
Feb 201075213
Mar 201060713
Apr 20105539
May 201061107
Jun 201068125
Jul 20103375
Aug 20104916
Sep 20103642
Oct 20103889
Nov 20102634
Dec 201021256
Jan 2011171715
Feb 2011223418
Mar 2011173413
Apr 2011273925
May 2011183913
Jun 2011161415
Jul 2011252416
Aug 2011162922
Sep 2011313556
Oct 2011313641
Nov 2011284136
Dec 2011273121
Jan 2012183932
Feb 2012265324
Mar 2012424173
Apr 2012292091
May 20121630251
Jun 20124023214
Jul 20123521110
Aug 20122227134
Sep 20121932161
Oct 20124823269
Nov 2012543455
Dec 2012232430
Jan 2013274138
Feb 2013202828
Mar 2013152018
Apr 2013243118
May 2013223526
Jun 2013131813
Jul 201352396
Aug 201362419
Sep 2013172836
Oct 201315246
Nov 2013182814
Dec 201310134
Jan 201414133
Feb 201481511
Mar 2014162712
Apr 201462425
May 201413158
Jun 201412366
Jul 20145225
Aug 20144204
Sep 201410249
Oct 2014151421
Nov 201491711
Dec 201481410
Jan 201512286
Feb 201581313
Mar 2015122814
Apr 20155135
May 201510379
Jun 201511173
Jul 2015141412
Aug 201521268
Sep 20152103
Oct 20159135
Nov 201510127
Dec 20151356
Jan 201610138
Feb 2016767
Mar 20167721
Apr 20167146
May 20168135
Jun 2016744
Jul 2016744
Aug 20161123
Sep 2016794
Oct 201652511
Nov 2016362
Dec 20162177
Jan 20171163
Feb 2017091
Mar 20170205
Apr 20171122
May 20178129
Jun 2017694
Jul 2017045
Aug 201781313
Sep 201751211
Oct 201701511
Nov 201752416
Dec 20174154
Jan 20181124
Feb 201821312
Mar 201802113
Apr 20180174
May 201801613
Jun 201812610
Jul 2018078
Aug 20180112
Sep 20180235
Oct 20181429
Nov 20180595
Dec 201845115
Jan 20194915
Feb 20195336
Mar 201927010
Apr 201913018
May 20191214
Jun 20195111
Jul 20191406
Aug 20191708
Sep 20191102
Oct 20191522
Nov 20194412
Dec 20191634
Jan 20201600
Feb 20201900
Mar 2020935
Apr 2020400
May 2020500
Jun 2020800
Jul 2020610
Aug 2020614
Sep 2020311
Oct 2020701
Nov 2020502
Dec 2020900
Jan 20211032

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 37 (12)
Drug Metabolism and Disposition
Vol. 37, Issue 12
1 Dec 2009
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The uPA(+/+)-SCID Mouse with Humanized Liver as a Model for in Vivo Metabolism of 4-Androstene-3,17-dione
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The uPA(+/+)-SCID Mouse with Humanized Liver as a Model for in Vivo Metabolism of 4-Androstene-3,17-dione

Leen Lootens, Peter Van Eenoo, Philip Meuleman, Geert Leroux-Roels and Frans T. Delbeke
Drug Metabolism and Disposition December 1, 2009, 37 (12) 2367-2374; DOI: https://doi.org/10.1124/dmd.109.028183

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

The uPA(+/+)-SCID Mouse with Humanized Liver as a Model for in Vivo Metabolism of 4-Androstene-3,17-dione

Leen Lootens, Peter Van Eenoo, Philip Meuleman, Geert Leroux-Roels and Frans T. Delbeke
Drug Metabolism and Disposition December 1, 2009, 37 (12) 2367-2374; DOI: https://doi.org/10.1124/dmd.109.028183
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments.
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • BSEP Function in Suspension Hepatocytes
  • Candesartan glucuronide serves as a CYP2C8 inhibitor
  • Role of AADAC on eslicarbazepine acetate hydrolysis
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics